Nationwide Fund Advisors - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 118 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$66,000
-35.9%
49,500
-24.8%
0.00%
Q2 2017$103,000
-67.1%
65,838
-32.1%
0.00%
-100.0%
Q1 2017$313,000
+645.2%
96,918
+211.8%
0.00%
Q4 2016$42,000
-12.5%
31,0800.0%0.00%
Q3 2016$48,000
+17.1%
31,0800.0%0.00%
Q2 2016$41,000
-89.4%
31,080
-57.6%
0.00%
-100.0%
Q1 2016$386,000
-36.1%
73,255
-4.9%
0.00%
-33.3%
Q4 2015$604,000
-6.8%
76,994
+0.3%
0.00%0.0%
Q3 2015$648,000
-24.9%
76,742
-2.6%
0.00%
-25.0%
Q2 2015$863,000
+20.0%
78,792
+53.2%
0.00%
+33.3%
Q1 2015$719,000
-18.8%
51,421
-1.9%
0.00%
-25.0%
Q4 2014$886,000
+76.1%
52,440
+40.0%
0.00%
+100.0%
Q3 2014$503,000
+5.7%
37,450
+0.2%
0.00%0.0%
Q2 2014$476,000
+8.2%
37,357
+1.0%
0.00%0.0%
Q1 2014$440,000
-47.2%
36,995
-38.8%
0.00%
-33.3%
Q4 2013$834,000
-22.3%
60,415
-1.7%
0.00%
-40.0%
Q3 2013$1,073,000
+131.7%
61,468
+115.9%
0.01%
+150.0%
Q2 2013$463,00028,4720.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
BVF INC/IL 17,426,968$36,945,0001.45%
Opaleye Management Inc. 3,171,800$6,724,0000.88%
EAM Investors, LLC 421,103$893,0000.15%
Bleichroeder LP 250,000$530,0000.10%
PLATINUM INVESTMENT MANAGEMENT LTD 755,593$1,602,0000.04%
Callan Capital, LLC 73,200$155,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 419,300$889,0000.02%
Private Wealth Advisors, Inc. 12,000$25,0000.01%
Alpine Global Management, LLC 24,575$52,0000.01%
Evercore Wealth Management, LLC 143,138$303,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders